List of works by Edurne Arriola

A complex deletion/insertion on exon 19 of the EGFR gene predicts response to gefitinib.

scientific article

ALK status in a primary lung tumour and metachronous metastases.

scientific article

Accurate Identification of Predictive Biomarkers of Response to Targeted Therapies in Lung Cancer With Next Generation Sequencing

scientific article published on 20 September 2018

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

scientific article

Activating and resistance mutations of the epidermal growth factor receptor (EGFR) gene and non-small cell lung cancer: a clinical reality ⬇️

scientific article published on 01 August 2010

An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.

scientific article published on 24 July 2016

Angiopoietin-2 is a negative prognostic marker in small cell lung cancer.

scientific article

Aromatase inhibitors and male breast cancer.

scientific article published in March 2007

Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.

scientific article published in December 2014

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study

scientific article published on 23 July 2019

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

scientific article published on 27 November 2017

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

scientific article published on 10 August 2017

Case Report: CD103+CD8+ lymphocytes characterize the immune infiltration in a case with pseudoprogression in SqNSCLC.

scientific article

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.

scientific article published on 18 February 2016

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

scientific article published on 30 January 2018

Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.

scientific article published on 5 April 2018

Cutaneous recall phenomenon with vinorelbine

scientific article published on 23 August 2011

Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma

scientific article published on 23 March 2018

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma

scientific article published on 17 April 2019

EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia.

scientific article published on 23 August 2012

Early Onset Pulmonary Toxicity With Lorlatinib in a Patient With Previous Pulmonary Toxicity From Brigatinib

scientific article published on 01 November 2019

Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis

scientific article published on 15 July 2016

Genetic changes in small cell lung carcinoma.

scientific article published on April 2008

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.

scientific article

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients

scientific article

Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer

scientific article published on 01 April 2006

Immunosuppression for ipilimumab-related toxicity can cause pneumocystis pneumonia but spare antitumor immune control.

scientific article published on 27 May 2015

Immunotherapy is Here to Stay: A New Treatment Paradigm in Lung Cancer

scientific article published on 05 October 2018

Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer

scientific article

Infliximab for IPILIMUMAB-Related Colitis--Letter

scientific article published on 01 December 2015

Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?

scientific article

MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside

scientific article published on 20 September 2019

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).

scientific article

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

scientific article

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus.

scientific article published on 18 December 2014

Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel

scientific article

Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.

scientific article

Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns

scientific article published on 26 February 2019

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

scientific article published on 10 June 2016

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma

scientific article published on 28 November 2016

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours

scientific article

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer.

scientific article published on 20 June 2013

Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer

scientific article published on 28 August 2006

ROS1 copy number alterations are frequent in non-small cell lung cancer

scientific article published on 15 January 2016

Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

scientific article published in September 2005

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

scientific article published on 27 March 2019

TG4010: a vaccine with a therapeutic role in cancer

scientific article published on May 2016

Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.

scientific article published on 27 November 2013

Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer

scientific article published on 27 January 2007

Two rare exon 21 EGFR mutations in patients treated with gefitinib.

scientific article published in April 2013

[Metastatic intestinal perforation secondary to a primary lung tumour]

scientific article published on 04 July 2009

[Two cases of pituitary metastases as initial presentation form of small cell lung cancer]

scientific article published on 01 December 2012

Paulina is supported by:

About Paulina

Help